WHO Drug Information - Volume 39, No. 3
3 October 2025
| Publication
Overview
The Third issue of volume 39 for 2025 includes:
Consultation Documents:
- Cefiderocol sulfate tosilate (cefiderocoli sulfas tosilatum)
- Cefiderocol powder for concentrate for solution for infusion (cefiderocoli pulvis pro concentrato pro solutione pro infusione)
- Gliclazide sustained-release tablets (gliclazidum compressi prolongati)
- Gliclazide (gliclazidum)
- 1.18 High performance thin-layer chromatography
- Determination of diethylene glycol and ethylene glycol in liquid preparations for oral use
- Draft revision of chapter 2.11: micro determination of water by the Karl Fischer method
Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) Classification:
- ATC/DDD Classification (Temporary)
- ATC/DDD Classification (Final)
Volume 39, issue 3 concludes with the International Nonproprietary Names (INN) List - Recommended INN List No. 94
WHO Team
Access to Medicines and Health Products (MHP),
INN and Classification of Medical Products (INN),
Prequalification (PQT),
Regulation and Prequalification (RPQ),
Regulation and safety (REG)
Editors
World Health Organization
Number of pages
312
Reference numbers
ISBN: 9789240115507
Copyright
